Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - PowerPoint PPT Presentation

Loading...

PPT – Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 PowerPoint presentation | free to download - id: 812c2b-NWNkN



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Breast Cancer Therapeutics in Asia-Pacific Markets to 2021

Description:

Breast cancer, a malignant neoplasm, is the second-most common cancer and the most common cancer in women worldwide, accounting for 16% of all female cancers, making the disease exceedingly prevalent. For More Information: – PowerPoint PPT presentation

Number of Views:12

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Breast Cancer Therapeutics in Asia-Pacific Markets to 2021


1
Breast Cancer Therapeutics in Asia-Pacific
Markets to 2021 - Growth Driven by Increasing
Uptake of Premium Priced Biologics and Rising
Prevalence
To buy this Report Visit http//www.jsbmarketresea
rch.com
2
Summary
  •  Breast cancer, a malignant neoplasm, is the
    second-most common
  • cancer and the most common cancer in women
    worldwide,
  • accounting for 16 of all female cancers, making
    the disease
  • exceedingly prevalent. In the past, breast cancer
    occurred less in
  • women in Asia than women in Western countries.
    However, recent
  • studies show that breast cancer is being
    diagnosed more
  • frequently in women living in Asia, especially
    among younger
  • women.
  • The marketed products landscape comprises a wide
    range of
  • treatment options, including hormonal therapies,
    chemotherapies,
  • combination therapies and targeted therapies.  

g
3
 Scope
  • The current breast cancer market contains novel
    products, including
  • Perjeta, a targeted therapy Kadcyla, a human
    antibody-drug conjugate
  • and Halaven, a novel chemotherapeutic agent. -
    What are the competitive advantages of the
    existing novel drugs? - Are these targeted
    therapies used to the same magnitude in all the
    countries assessed? - What are the factors
    contributing to the uptake of these drugs in each
    country? With over 700 active pipeline
    molecules, most of the investigational drug
    candidates are being evaluated for the first-line
    or second-line treatment of advanced-stage breast
    cancer, featuring new combination therapies,
    targeted therapies, and promising
    immunotherapies, as well as chemotherapy drug
    candidates.

g
4
 Reasons to buy
  • This report will enable you to - 
  • Understand the clinical context of breast cancer
    by considering symptoms, etiology,
    pathophysiology, epidemiology, diagnosis, and
    treatment options
  •  - Identify the therapeutic strategies, products,
    and companies that dominate the current marketed
    products landscape and recognize gaps and areas
    of unmet need
  •  - Identify key pipeline trends in molecule type,
    administration route, mechanism of action, and
    novelty
  •  - Consider market opportunities and potential
    risks by examining trends in breast cancer
    clinical trial size, duration, and failure rate
    by stage of development, molecule type, and
    mechanism of action 

g
5
Table Of Content
2 Introduction 9 2.1 Disease Introduction
9 2.2 Symptoms 10 2.3 Etiology 10 2.4
Pathophysiology 11 2.5 Epidemiology 12 2.6
Diagnosis and Classification 14 2.7 Prognosis
and Disease Staging 16 2.8 Treatment Options
18 2.8.1 Surgery and Radiation Therapy 18 2.8.2
Chemotherapy 19 2.8.3 Hormonal Therapies
19 2.8.4 Targeted Therapies 20 2.8.5 Resistance
to Pharmacological Therapies 20 2.9 Treatment
Guidelines 21
g
6
Related Market Research Report
  • Hormone Refractory Breast Cancer-Pipeline
    Insights, 2016US
  • Breast Cancer Imaging Industry 2015 Market
    Research
  • Global Breast Cancer Imaging Industry 2015 Market
    Research ReportReport
  • Breast Cancer Treatment Drug Companies in China
  • Breast Cancer Treatment Drug Industry Forecasts -
    China Focus
  • Breast Cancer Treatment Drug Markets in China
  • Metastatic Breast Cancer - Pipeline Review, H1
    2015

g
7
About JSB Market Research
  • JSBMarketResearch.Com is an online repository of
    an extensive collection of market
  • research reports available online. This online
    portal contains high quality reports
  • with well-researched and high quality content on
    a wide range of industries. These
  • market research reports help us give a detailed
    insight into new opportunities in
  • The industry, prevailing market trends,
    competitor analysis and future
  • prospects.
  • JSBs reports are developed by the domain experts
    and publishers under a closely
  • observed surveillance of industry specialists in
    Online Database.Therefore, the
  • researched data is well researched, well-
    organized and matching up to the best
  • standards in the industry. Also JSBs database
    consists of detailed insights of the
  • leading players in the global market, products
    and trends also find latest updates on
  • global conference events.

g
8
To Know More
  • http//www.jsbmarketresearch.com/healthcare-medica
    l/r-breast-cancer-therapeutics-in-asia-pacific-mar
    kets-151132
  • Contact Details
  • JSB Market Research
  • Phone 91 - 998 729 5242
  • Email - enquiry_at_jsbmarketresearch.com
  • Website http//www.jsbmarketresearch.com

g
About PowerShow.com